Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
One startup, H3 Biomedicines, uses genome data to design drugs aimed at small groups of patients.
A new technique can make tailor-made proteins evolve in days, not years.
Nanotechnology-based drug delivery offers new treatment options for deadly pancreatic cancers.
A new approach to preventing cancer teaches the immune system to seek and destroy emerging tumors.
Why does Genentech’s anticancer drug work better for some patients than for others?